Severe immune-mediated thrombocytopenia after intravitreal bevacizumab injection

Conclusion: The case presented shows apparent severe immune-mediated thrombocytopenia after intravitreal bevacizumab administration.
Source: Retinal Cases and Brief Reports - Category: Opthalmology Tags: Case Report Source Type: research